Matthew Brown

Title: Matthew Brown - Innovator in Induced Pluripotent Stem Cell Research

Introduction

Matthew Brown is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of cellular biology, particularly in the area of induced pluripotent stem cells (iPS cells). With a total of 2 patents, his work has the potential to impact regenerative medicine and therapeutic applications.

Latest Patents

Matthew Brown's latest patents focus on reprogramming T cells and hematopoietic cells. The methods and compositions he developed relate to the production of induced pluripotent stem cells. For instance, his inventions disclose that iPS cells can be generated from CD34 hematopoietic cells, such as human CD34 blood progenitor cells, or T cells. Additionally, various iPS cell lines are provided, and certain embodiments of his invention offer novel induced pluripotent stem cells with a genome that includes genetic rearrangement of T cell receptors.

Career Highlights

Throughout his career, Matthew has worked with notable companies in the biotechnology sector. He has been associated with Fujifilm Cellular Dynamics, Inc. and Cellular Dynamics International, Inc. His experience in these organizations has allowed him to advance his research and contribute to innovative solutions in cellular reprogramming.

Collaborations

Matthew has collaborated with several professionals in his field, including Elizabeth Rondon Dominguez and Randy Learish. These collaborations have enriched his research and expanded the scope of his inventions.

Conclusion

Matthew Brown is a key figure in the development of induced pluripotent stem cell technology. His innovative patents and collaborations highlight his commitment to advancing the field of cellular biology. His work continues to pave the way for future breakthroughs in regenerative medicine.